Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adri C Voogd

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Breast Cancer Research and Treatment|August 10, 2020
Local staging of ipsilateral breast tumor recurrence: mammography, ultrasound, or MRI?Coco J E F Walstra, Robert-Jan Schipper, Gonneke A Winter-Warnars, et al.
Annals of Surgical Oncology|June 24, 2016
Type and Extent of Surgery for Screen-Detected and Interval Cancers at Blinded Versus Nonblinded Double-Reading in a Population-Based Screening Mammography ProgramRoy J P Weber, Rob M G van Bommel, Wikke Setz-Pels, et al.
Breast (Edinburgh, Scotland)|October 27, 2023
Trends in the pre-operative diagnosis and surgical management of axillary lymph node metastases in women with screen-detected breast cancerLucien E M Duijm, Luc J A Strobbe, Vivian van Breest Smallenburg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 2021
Rate and predictors of nodal pathological complete response following neoadjuvant endocrine treatment in clinically biopsy-proven node-positive breast cancer patientsRobert-Jan Schipper, Anne de Bruijn, Adri C Voogd, et al.
Cancer Medicine|September 20, 2022
Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohortDelal Akdeniz, Iris Kramer, Carolien H M van Deurzen, et al.
European Journal of Radiology|June 9, 2022
Effects of nonparticipation at previous screening rounds on the characteristics of screen-detected breast cancersLucien E M Duijm, Mireille J M Broeders, Wikke Setz-Pels, et al.
The Breast Journal|May 14, 2013
Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the NetherlandsMyrthe P P van Herk-Sukel, Lonneke V van de Poll-Franse, Geert-Jan Creemers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 28, 2008
The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancerLindy A Diepenmaat, Maurice J C van der Sangen, Lonneke V van de Poll-Franse, et al.
Cancer|March 31, 2007
The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 yearsMarloes van der Leest, Lisette Evers, Maurice J C van der Sangen, et al.
The Oncologist|March 25, 2016
Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer ConsortiumShanly C Seferina, Maaike de Boer, M Wouter Derksen, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Breast Cancer Research and Treatment|August 10, 2020
Local staging of ipsilateral breast tumor recurrence: mammography, ultrasound, or MRI?Coco J E F Walstra, Robert-Jan Schipper, Gonneke A Winter-Warnars, et al.
Annals of Surgical Oncology|June 24, 2016
Type and Extent of Surgery for Screen-Detected and Interval Cancers at Blinded Versus Nonblinded Double-Reading in a Population-Based Screening Mammography ProgramRoy J P Weber, Rob M G van Bommel, Wikke Setz-Pels, et al.
Breast (Edinburgh, Scotland)|October 27, 2023
Trends in the pre-operative diagnosis and surgical management of axillary lymph node metastases in women with screen-detected breast cancerLucien E M Duijm, Luc J A Strobbe, Vivian van Breest Smallenburg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 2021
Rate and predictors of nodal pathological complete response following neoadjuvant endocrine treatment in clinically biopsy-proven node-positive breast cancer patientsRobert-Jan Schipper, Anne de Bruijn, Adri C Voogd, et al.
Cancer Medicine|September 20, 2022
Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohortDelal Akdeniz, Iris Kramer, Carolien H M van Deurzen, et al.
European Journal of Radiology|June 9, 2022
Effects of nonparticipation at previous screening rounds on the characteristics of screen-detected breast cancersLucien E M Duijm, Mireille J M Broeders, Wikke Setz-Pels, et al.
The Breast Journal|May 14, 2013
Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the NetherlandsMyrthe P P van Herk-Sukel, Lonneke V van de Poll-Franse, Geert-Jan Creemers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 28, 2008
The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancerLindy A Diepenmaat, Maurice J C van der Sangen, Lonneke V van de Poll-Franse, et al.
Cancer|March 31, 2007
The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 yearsMarloes van der Leest, Lisette Evers, Maurice J C van der Sangen, et al.
The Oncologist|March 25, 2016
Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer ConsortiumShanly C Seferina, Maaike de Boer, M Wouter Derksen, et al.
Pageof 16